HU-243

From WikiMD's WELLNESSPEDIA

HU-243 is a synthetic cannabinoid that has been used in scientific research. It is a highly potent full agonist of the CB1 receptor, with a Ki of 0.06nM, making it around 25x more potent than THC.

Chemistry[edit]

HU-243 is part of a series of 1,1-dimethylheptyl tetrahydrocannabinols, which includes HU-210, HU-211, HU-239, HU-244, and HU-245. These compounds are all analogs of THC, with the 1,1-dimethylheptyl side chain increasing potency.

Pharmacology[edit]

HU-243, like other synthetic cannabinoids, acts as a full agonist at the CB1 receptor. This results in effects similar to those of THC, but with greater potency. The exact mechanisms of action of HU-243 are not fully understood, but it is thought to interact with the endocannabinoid system in a similar way to other cannabinoids.

Research[edit]

Research into HU-243 and other synthetic cannabinoids has focused on their potential therapeutic uses, as well as their effects on the brain and body. Studies have shown that HU-243 can have anti-inflammatory, analgesic, and antiemetic effects, among others.

Legal Status[edit]

The legal status of HU-243 varies by country. In some places, it is classified as a controlled substance, while in others it is legal for research purposes.

See Also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

  • HU-243 Structure
    HU-243 Structure

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=HU-243&oldid=6333319"